152 related articles for article (PubMed ID: 31109249)
1. Implementing a personalized medicine cancer program in a community cancer system.
Dressler LG; Bell GC; Schuetze DP; Steciuk MR; Binns OA; Raab RE; Abernathy PM; Wilson CM; Kunutsor SE; Loveless MC; Ahearne PM; Messino MJ
Per Med; 2019 May; 16(3):221-232. PubMed ID: 31109249
[No Abstract] [Full Text] [Related]
2. Genomics, personalized medicine, and supportive cancer care.
Sonis ST
Am Soc Clin Oncol Educ Book; 2015; ():9-16. PubMed ID: 25993135
[No Abstract] [Full Text] [Related]
3. Implementing a personalized medicine program in a community health system.
Dressler LG; Bell GC; Ruch KD; Retamal JD; Krug PB; Paulus RA
Pharmacogenomics; 2018 Nov; 19(17):1345-1356. PubMed ID: 30345883
[TBL] [Abstract][Full Text] [Related]
4. Early Lessons from the Implementation of Genomic Medicine Programs.
Williams MS
Annu Rev Genomics Hum Genet; 2019 Aug; 20():389-411. PubMed ID: 30811224
[TBL] [Abstract][Full Text] [Related]
5. Genetics and genomics: the scientific drivers of personalized medicine.
Kurnat-Thoma EL
Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
[TBL] [Abstract][Full Text] [Related]
6. The role and impact of SNPs in pharmacogenomics and personalized medicine.
Laing RE; Hess P; Shen Y; Wang J; Hu SX
Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
[TBL] [Abstract][Full Text] [Related]
7. Implementing Precision Medicine in Community-Based Oncology Programs: Three Models.
Levit LA; Kim ES; McAneny BL; Nadauld LD; Levit K; Schenkel C; Schilsky RL
J Oncol Pract; 2019 Jun; 15(6):325-329. PubMed ID: 30802151
[TBL] [Abstract][Full Text] [Related]
8. Clinical implementation of personalized medicine in community pharmacies: considerations for clinicians.
Bright DR; Greco AJ; Langerveld A; Kisor DF
Per Med; 2017 Nov; 14(6):471-475. PubMed ID: 29749860
[No Abstract] [Full Text] [Related]
9. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
Maggi E; Montagna C
Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
[TBL] [Abstract][Full Text] [Related]
10. The Promise and the Reality of Genomics to Guide Precision Medicine in Pediatric Oncology: The Decade Ahead.
Evans WE; Pui CH; Yang JJ
Clin Pharmacol Ther; 2020 Jan; 107(1):176-180. PubMed ID: 31563145
[TBL] [Abstract][Full Text] [Related]
11. Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).
Ozdemir V; Endrenyi L; Aynacıoğlu S; Bragazzi NL; Dandara C; Dove ES; Ferguson LR; Geraci CJ; Hafen E; Kesim BE; Kolker E; Lee EJ; Llerena A; Nacak M; Shimoda K; Someya T; Srivastava S; Tomlinson B; Vayena E; Warnich L; Yaşar U
OMICS; 2014 Apr; 18(4):211-21. PubMed ID: 24649998
[TBL] [Abstract][Full Text] [Related]
12. The opportunities and challenges of implementing genomics-informed personalized medicine.
Chisholm RL
Clin Pharmacol Ther; 2013 Aug; 94(2):181-2. PubMed ID: 23872829
[No Abstract] [Full Text] [Related]
13. Response to "personalized medicine, genomics, and pharmacogenomics".
Mayer DK
Clin J Oncol Nurs; 2014 Dec; 18(6):618. PubMed ID: 25427694
[No Abstract] [Full Text] [Related]
14. Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
Tsongalis GJ; Coleman WB
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S60-S66. PubMed ID: 28921651
[TBL] [Abstract][Full Text] [Related]
15. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
16. The integration of genomics testing and functional proteomics in the era of personalized medicine.
Katoh M
Expert Rev Proteomics; 2017 Dec; 14(12):1055-1058. PubMed ID: 29039218
[No Abstract] [Full Text] [Related]
17. Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.
Rahm AK; Cragun D; Hunter JE; Epstein MM; Lowery J; Lu CY; Pawloski PA; Sharaf RN; Liang SY; Burnett-Hartman AN; Gudgeon JM; Hao J; Snyder S; Gogoi R; Ladd I; Williams MS
BMC Health Serv Res; 2018 Oct; 18(1):824. PubMed ID: 30376847
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics in the age of personalized medicine.
Dickmann LJ; Ware JA
Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
[TBL] [Abstract][Full Text] [Related]
19. Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities.
Saulsberry L; Olopade OI
Cancer Cell; 2021 Jun; 39(6):730-733. PubMed ID: 34019805
[No Abstract] [Full Text] [Related]
20. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
